SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BAIN CAPITAL VENTURE INVESTORS, LLC

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SmartRent, Inc. [ SMRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/27/2022 S 80,021 D $4.9662(4) 20,414,706 I See footnotes(1)(2)(3)
Class A Common Stock 07/28/2022 S 74,691 D $5.3304(5) 20,340,015 I See footnotes(1)(2)(3)
Class A Common Stock 07/29/2022 S 51,967 D $5.6196(6) 20,288,048 I See footnotes(1)(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
BAIN CAPITAL VENTURE INVESTORS, LLC

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Bain Capital Venture Fund 2019, L.P.

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Bain Capital Venture Investors 2019, LLC

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
BCV 2019-MD Primary, L.P.

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
BCIP Venture Associates II, L.P.

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
BCIP Venture Associates II-B, LP

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Salem Enrique T

(Last) (First) (Middle)
C/O BAIN CAPITAL VENTURE INVESTORS,
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Agarwal Ajay

(Last) (First) (Middle)
C/O BAIN CAPITAL VENTURE INVESTORS,
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Bain Capital Venture Investors, LLC ("BCVI") is the manager of Bain Capital Venture Investors 2019, LLC ("BCVI 2019"), which is the general partner of each of Bain Capital Venture Fund 2019, L.P. ("BCV Fund 2019") and BCV 2019-MD Primary, L.P. ("BCV MD Primary"). As a result, BCVI 2019 may be deemed to share voting and dispositive power with respect to the shares of the Issuer's Class A Common Stock held by BCV Fund 2019 and BCV MD Primary. BCVI 2019 disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On July 27, 2022, July 28, 2022 and July 29, 2022, BCV Fund 2019 sold 69,676, 65,036 and 45,250 shares of the Issuer's Class A Common Stock, respectively, and BCV MD Primary sold 2,680, 2,501 and 1,740 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCV Fund 2019 and BCV MD Primary held 17,665,418 and 679,445 shares of the Issuer's Class A Common Stock, respectively.
2. Boylston Coinvestors, LLC is the general partner of each of BCIP Venture Associates II, L.P. ("BCIP Venture II") and BCIP Venture Associates II-B, LP ("BCIP Venture II-B" and, together with BCV Fund 2019, BCV MD Primary and BCIP Venture II, the "Bain Capital Venture Entities"). On July 27, 2022, July 28, 2022 and July 29, 2022, BCIP Venture II sold 7,089, 6,616 and 4,603 shares of the Issuer's Class A Common Stock, respectively, and BCIP Venture II-B sold 576, 538 and 374 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCIP Venture II and BCIP Venture II-B held 1,797,183 and 146,002 shares of the Issuer's Class A Common Stock, respectively.
3. The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Venture Entities is directed by the Executive Committee of BCVI, which consists of Enrique Salem and Ajay Agarwal. As a result, BCVI and Messrs. Salem and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Venture Entities. BCVI and Messrs. Salem and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.86 to $5.10, inclusive. The reporting persons undertake to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4.
5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.04 to $5.46, inclusive.
6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.36 to $5.71, inclusive.
Remarks:
Bain Capital Venture Investors, LLC, By: /s/ Paul Zurlo, Title: Managing Director 07/29/2022
Bain Capital Venture Fund 2019, L.P., By: Bain Capital Venture Investors 2019, LLC, its general partner, By: Bain Capital Venture Investors, LLC, its manager, By: /s/ Paul Zurlo, Title: Managing Director 07/29/2022
Bain Capital Venture Investors 2019, LLC, By: Bain Capital Venture Investors, LLC, its manager, By: /s/ Paul Zurlo, Title: Managing Director 07/29/2022
BCV 2019-MD Primary, L.P., By: Bain Capital Venture Investors 2019, LLC, its general partner, By: Bain Capital Venture Investors, LLC, its manager, By: /s/ Paul Zurlo, Title: Managing Director 07/29/2022
BCIP Venture Associates II, L.P., By: Boylston Coinvestors, LLC, its general partner, By: /s/ Paul Zurlo, Title: Authorized Signatory 07/29/2022
BCIP Venture Associates II-B, LP, By: Boylston Coinvestors, LLC, its general partner, By: /s/ Paul Zurlo, Title: Authorized Signatory 07/29/2022
/s/ Enrique T. Salem 07/29/2022
/s/ Ajay Agarwal 07/29/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.